Literature DB >> 16893148

Is it time for single-inhaler asthma therapy?

Anthony D D'Urzo1, Vasant Solanki.   

Abstract

Year:  2006        PMID： 16893148      PMCID： PMC1781087     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  9 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

2.  Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.

Authors:  A E Tattersfield; C G Löfdahl; D S Postma; A Eivindson; A G Schreurs; A Rasidakis; T Ekström
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

3.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

4.  Adult Asthma Consensus Guidelines update 2003.

Authors:  Catherine Lemière; Tony Bai; Meyer Balter; Charles Bayliff; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Andrew Cave; Kenneth Chapman; Robert Cowie; Stephen Coyle; Donald Cockcroft; Francine M Ducharme; Pierre Ernst; Shelagh Finlayson; J Mark FitzGerald; Frederick E Hargreave; Donna Hogg; Alan Kaplan; Harold Kim; Cheryle Kelm; Paul O'Byrne; Malcolm Sears; Andrea White Markham
Journal:  Can Respir J       Date:  2004 May-Jun       Impact factor: 2.409

5.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Authors:  Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

6.  Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.

Authors:  Hanneke J van der Woude; Martin Boorsma; Peter B F Bergqvist; Trea H Winter; René Aalbers
Journal:  Pulm Pharmacol Ther       Date:  2004       Impact factor: 3.410

7.  Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.

Authors:  A P Greening; P W Ind; M Northfield; G Shaw
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

8.  Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.

Authors:  A Woolcock; B Lundback; N Ringdal; L A Jacques
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

9.  Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial.

Authors:  R A Pauwels; M R Sears; M Campbell; C Villasante; S Huang; A Lindh; W Petermann; M Aubier; G Schwabe; T Bengtsson
Journal:  Eur Respir J       Date:  2003-11       Impact factor: 16.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.